KALA BIO, Inc. (KALA) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2025-11-26

KALA BIO, Inc. (KALA) — no SEC Form 4 insider filings recorded in the last 90 days. 7 Form 8-K material event filings were reported by KALA in the last 90 days. InsiderAlpha tracks every KALA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About KALA BIO, Inc. (KALA)

SIC classification	Pharmaceutical Preparations (SIC 2834)
SEC CIK	0001479419

90-Day SEC Filing Activity

Form 8-K filings (90d)	7
Latest Form 4 filing	2025-11-26

Recent KALA Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-10-01	BAKER BROS. ADVISORS LP	Insider	S — Open-market sale	50.6K	$1.38	$70K	SEC
2025-10-01	BAKER BROS. ADVISORS LP	Insider	S — Open-market sale	463.0K	$1.38	$641K	SEC
2025-09-30	BAKER BROS. ADVISORS LP	Insider	S — Open-market sale	21.4K	$1.60	$34K	SEC
2025-09-30	BAKER BROS. ADVISORS LP	Insider	S — Open-market sale	195.4K	$1.60	$312K	SEC
2025-06-24	Brazzell Romulus K	SEE REMARKS	S — Open-market sale	5.3K	$4.01	$21K	SEC
2025-06-15	PERRY GREGORY D	Insider	A — Grant or award	2.5K	$0.00	—	SEC
2025-06-15	KOVEN ANDREW I	Insider	A — Grant or award	3.0K	$0.00	—	SEC
2025-06-15	Rosen Howard B	Insider	A — Grant or award	2.5K	$0.00	—	SEC
2025-06-03	Brazzell Romulus K	SEE REMARKS	S — Open-market sale	3.7K	$3.74	$14K	SEC
2024-12-30	BAKER BROS. ADVISORS LP	Insider	P — Open-market purchase	279.9K	$6.44	$1.80M	SEC
2024-12-30	BAKER BROS. ADVISORS LP	Insider	P — Open-market purchase	30.6K	$6.44	$197K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for KALA BIO, Inc. (KALA). Updated in real time as new filings are submitted to the SEC.

Recent KALA Form 8-K Material Events

2026-05-11 — Other · neutral [SEC]
Trading halt (T3) for KALA. KALA
2026-05-11 — Other · neutral [SEC]
Trading halt (T3) for KALA. KALA
2026-05-10 — Other · neutral [SEC]
Trading halt (T1) for KALA. KALA
2026-05-10 — Other · neutral [SEC]
Trading halt (T1) for KALA. KALA
2026-05-10 — Other · neutral [SEC]
Trading halt (T1) for KALA. KALA

Recent Insider Filings

2025-11-26 — Lazar David E. (Chief Executive Officer)
2025-10-24 — Iwicki Mark T (Insider)
2025-10-24 — Brazzell Romulus K (SEE REMARKS)
2025-10-24 — Bazemore Todd (Insider)
2025-10-24 — Reumuth Mary (CHIEF FINANCIAL OFFICER)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in KALA insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

KALA Insider Trading — FAQ

What is the latest insider trade for KALA?: KALA BIO, Inc. (KALA) had 0 insider filings in the last 90 days, with the most recent on 2025-11-26. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying KALA stock?: 0 insider purchases of KALA were filed in the last 90 days.
How many insiders are selling KALA stock?: 0 insider sales of KALA were filed in the last 90 days.
Where can I see KALA SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every KALA SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live KALA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.